Regulatory News:

Carmila (Paris:CARM) will publish its 2024 full-year results on Tuesday, February 11, 2025, after market close and will present the 2024 full-year results on Wednesday, February 12, 2025, at 09:00 am CET.

The presentation will be broadcast live and will later be available as a recording in the “Financial Presentations” section of Carmila's website.

INVESTOR AGENDA

February 11, 2025 (after market close): Publication of 2024 full-year results February 12, 2025 (09:00 am CET): Presentation of 2024 full-year results

ABOUT CARMILA

As the third-largest listed owner of commercial property in Europe, Carmila was founded by Carrefour and large institutional investors in order to enhance the value of shopping centres adjoining Carrefour hypermarkets in France, Spain and Italy. At June 30, 2024, its portfolio was valued at €5.9 billion and is made up of 201 shopping centres, with leading positions in their catchment areas.

Carmila is listed on Euronext-Paris Compartment A under the symbol CARM. It benefits from the tax regime for French real estate investment trusts (“SIIC”).

Carmila has been a member of the SBF 120 since June 20, 2022.

IMPORTANT NOTICE

Some of the statements contained in this document are not historical facts but rather statements of future expectations, estimates and other forward-looking statements based on management’s beliefs. These statements reflect such views and assumptions prevailing as of the date of the statements and involve known and unknown risks and uncertainties that could cause future results, performance or events to differ materially from those expressed or implied in such statements. Please refer to the most recent Universal Registration Document filed in French by Carmila with the Autorité des marchés financiers for additional information in relation to such factors, risks and uncertainties. Carmila has no intention and is under no obligation to update or review the forward-looking statements referred to above. Consequently, Carmila accepts no liability for any consequences arising from the use of any of the above statements.

This press release is available in the “Regulated Information” section of Carmila’s Finance webpage: https://www.carmila.com/en/finance/regulated-information/

Visit our website at www.carmila.com/en/

INVESTOR AND ANALYST CONTACT

Pierre-Yves Thirion - CFO pierre_yves_thirion@carmila.com +33 6 47 21 60 49

PRESS CONTACT

Elodie Arcayna – Corporate Communications Director elodie_arcayna@carmila.com +33 7 86 54 40 10

Carisma Therapeutics (NASDAQ:CARM)
Historical Stock Chart
From Dec 2024 to Jan 2025 Click Here for more Carisma Therapeutics Charts.
Carisma Therapeutics (NASDAQ:CARM)
Historical Stock Chart
From Jan 2024 to Jan 2025 Click Here for more Carisma Therapeutics Charts.